Search research articles
Contact Us
Filters
Showing results (151-160 of 163) with videos related to
Page
of 17
Sort By:
International Journal of Radiation Biology
|
April 1, 1991
Protection of pig epidermis against radiation-induced damage by the infusion of BW12C
G J van den Aardweg, J W Hopewell, G E Adams, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
|
December 1, 1980
Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains
G E Adams, I Ahmed, E D Clarke, et al.
British Journal of Cancer
|
April 1, 1994
Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro
C P Thomas, R M Dixon, M Tian, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins
M D Threadgill, P Webb, P O'Neill, et al.
Anti-Cancer Drug Design
|
July 1, 1991
Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers
M A Naylor, M A Stephens, I J Stratford, et al.
Journal of Medicinal Chemistry
|
July 18, 1997
2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivo
M A Naylor, M Jaffar, J Nolan, et al.
British Journal of Cancer
|
December 1, 1992
Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145
J C Bremner, G E Adams, J K Pearson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1996
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay
V K Langmuir, K R Laderoute, H L Mendonca, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
|
February 1, 1979
Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio
G E Adams, E D Clarke, P Gray, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxins
T C Jenkins, M A Naylor, P O'Neill, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 163) with videos related to
Sort By:
Page
of 17
International Journal of Radiation Biology
|
April 1, 1991
Protection of pig epidermis against radiation-induced damage by the infusion of BW12C
G J van den Aardweg, J W Hopewell, G E Adams, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
|
December 1, 1980
Structure-activity relationships in the development of hypoxic cell radiosensitizers. III. Effects of basic substituents in nitroimidazole sidechains
G E Adams, I Ahmed, E D Clarke, et al.
British Journal of Cancer
|
April 1, 1994
Phosphorus metabolism during growth of lymphoma in mouse liver: a comparison of 31P magnetic resonance spectroscopy in vivo and in vitro
C P Thomas, R M Dixon, M Tian, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins
M D Threadgill, P Webb, P O'Neill, et al.
Anti-Cancer Drug Design
|
July 1, 1991
Aziridinyl nitropyrroles and nitropyrazoles as hypoxia-selective cytotoxins and radiosensitizers
M A Naylor, M A Stephens, I J Stratford, et al.
Journal of Medicinal Chemistry
|
July 18, 1997
2-Cyclopropylindoloquinones and their analogues as bioreductively activated antitumor agents: structure-activity in vitro and efficacy in vivo
M A Naylor, M Jaffar, J Nolan, et al.
British Journal of Cancer
|
December 1, 1992
Increasing the effect of photodynamic therapy on the RIF-1 murine sarcoma, using the bioreductive drugs RSU1069 and RB6145
J C Bremner, G E Adams, J K Pearson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1996
Fused pyrazine mono-n-oxides as bioreductive drugs. II Cytotoxicity in human cells and oncogenicity in a rodent transformation assay
V K Langmuir, K R Laderoute, H L Mendonca, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
|
February 1, 1979
Structure-activity relationships in the development of hypoxic cell radiosensitizers. II. Cytotoxicity and therapeutic ratio
G E Adams, E D Clarke, P Gray, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and evaluation of alpha-[[(2-haloethyl)amino]methyl]-2- nitro-1H-imidazole-1-ethanols as prodrugs of alpha-[(1-aziridinyl)methyl]-2- nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogues which are radiosensitizers and bioreductively activated cytotoxins
T C Jenkins, M A Naylor, P O'Neill, et al.
Page
of 17